ARROWHEAD PHARMACEUTICALS, INC. (NASDAQ:ARWR) filed a Form 8-K with the Securities and Exchange Commission on January 12, 2026, disclosing a material event.
ARROWHEAD PHARMACEUTICALS, INC.'s stock currently trades at $0.00 with a market capitalization of $0. The company's stock moved following the disclosure.